MWA
GILD icon

Medallion Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Medallion Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Buy
1,576
+503
+47% +$70.4K 0.07% 237
2025
Q4 		$132K Buy
1,073
+3
+0.3% +$365 0.04% 309
2025
Q3 		$119K Buy
1,070
+4
+0.4% +$455 0.04% 326
2025
Q2 		$119K Buy
1,066
+4
+0.4% +$426 0.05% 322
2025
Q1 		$119K Buy
1,062
+122
+13% +$12.6K 0.05% 276
2024
Q4 		$94.7K Buy
+940
New +$84.6K 0.05% 309

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Medallion Wealth Advisors's GILD Position: Q1 2026 in Review

Medallion Wealth Advisors increased its Gilead Sciences (GILD) stake by 47% in Q1 2026, buying an estimated $70.4K and bringing the position to 1,576 shares worth $220K. The position accounts for 0.07% of the portfolio, ranked #237.

Medallion Wealth Advisors first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Medallion Wealth Advisors held 1,576 shares of Gilead Sciences worth $220K as of Q1 2026.
  • Medallion Wealth Advisors bought 503 Gilead Sciences shares in Q1 2026, an estimated $70.4K.
  • Gilead Sciences made up 0.07% of Medallion Wealth Advisors's portfolio in Q1 2026, its #237 holding.
  • Medallion Wealth Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.